Winter 2012 Vol. 22, No. 3: 2012 Annual Report

Download this entire issue or browse individual articles by title below.

Front Cover
Back Cover
 Inside Front Cover 
1Table of Contents 
2From the Desk of Rick Doblin, Ph.D.Rick Doblin, Ph.D.
3Annual Financial ReportRick Doblin, Ph.D.
10Clinical Research Update 
16MDMA-Assisted Therapy for PTSD: Momentum Towards Phase 3 and BeyondIan Richardson
20Foreword to Healing with Entactogens: Therapist and Patient Perspectives on MDMA-Assisted Group Psychotherapy by Torsten Passie, M.D.Ralph Metzner, Ph.D.
22MAPS Medical Marijuana Initiatives: Can Marijuana Ease Symptoms of PTSD for War Veterans?Melody Pupols, Ph.D.
26Zendo Project 2012: Harm Reduction in the Black Rock DesertLinnae Ponté
28Exploring Ayahuasca at Psychedelic Science 2013Stephan V. Beyer Ph.D., J.D. and Bia Labate, Ph.D.
29Consideration of Ayahuasca for the Treatment of Posttraumatic Stress DisorderJessica L. Nielson, Ph.D. and Julie D. Megler, MSN, NP-BC
32Conference Report: Global Ibogaine Therapist Alliance (GITA) Vancouver, Canada, October 2–6, 2012Thomas Kingsley Brown, Ph.D.
34Psychedelics Advance in Higher EducationThomas B. Roberts, Ph.D.
36Reforming Psychedelic Science and Policy: An Update from the Beckley FoundationAmanda Feilding
39Infographic: Treating PTSD with MDMA-Assisted Therapy 
40Psilocybin as Medicine: An Update from The Heffter Research InstituteDavid E. Nichols, Ph.D.
42MAPS: Who We Are 
44MAPS Membership 
 Inside Back Cover 
 Back Cover 
Inside Front Cover
Inside Back Cover